GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huadong Medicine Co Ltd (SZSE:000963) » Definitions » EV-to-FCF

Huadong Medicine Co (SZSE:000963) EV-to-FCF

: 24.94 (As of Today)
View and export this data going back to 2000. Start your Free Trial

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Huadong Medicine Co's Enterprise Value is ¥49,770 Mil. Huadong Medicine Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 was ¥1,996 Mil. Therefore, Huadong Medicine Co's EV-to-FCF for today is 24.94.

The historical rank and industry rank for Huadong Medicine Co's EV-to-FCF or its related term are showing as below:

SZSE:000963' s EV-to-FCF Range Over the Past 10 Years
Min: -467.15   Med: 45.06   Max: 477.29
Current: 24.5

During the past 13 years, the highest EV-to-FCF of Huadong Medicine Co was 477.29. The lowest was -467.15. And the median was 45.06.

SZSE:000963's EV-to-FCF is ranked worse than
52.15% of 512 companies
in the Drug Manufacturers industry
Industry Median: 22.12 vs SZSE:000963: 24.50

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-16), Huadong Medicine Co's stock price is ¥29.49. Huadong Medicine Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was ¥1.547. Therefore, Huadong Medicine Co's PE Ratio for today is 19.06.


Huadong Medicine Co EV-to-FCF Historical Data

The historical data trend for Huadong Medicine Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huadong Medicine Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-FCF
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.96 65.60 23.55 29.09 68.08

Huadong Medicine Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-FCF Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55.17 68.08 81.15 25.43 36.46

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Huadong Medicine Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Huadong Medicine Co EV-to-FCF Distribution

For the Drug Manufacturers industry and Healthcare sector, Huadong Medicine Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Huadong Medicine Co's EV-to-FCF falls into.



Huadong Medicine Co EV-to-FCF Calculation

Huadong Medicine Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=49769.562/1995.627
=24.94

Huadong Medicine Co's current Enterprise Value is ¥49,770 Mil.
Huadong Medicine Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,996 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Huadong Medicine Co  (SZSE:000963) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Huadong Medicine Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=29.49/1.547
=19.06

Huadong Medicine Co's share price for today is ¥29.49.
Huadong Medicine Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.547.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Huadong Medicine Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Huadong Medicine Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Huadong Medicine Co (SZSE:000963) Business Description

Traded in Other Exchanges
N/A
Address
468 Yan’an Road, Floor 7, 9 and 10, Gate No. 1, Building No. 1, Hangzhou, CHN, 310006
Huadong Medicine Co Ltd is engaged in the production and sales of antibiotics, proprietary Chinese medicine, chemical synthetic medicine and genetic engineering drugs products. It is also engaged in the wholesale, retail and distribution business of Chinese and western medicine, Chinese herbal medicine, medical apparatus, and instruments. The main business of the company is divided into pharmaceutical business sales and the industry of pharmaceutical. The product portfolio of the company includes Corbrin capsule, Cymusi, New Cyspin, Kasiping, Panlisu, Acarbose, and others.

Huadong Medicine Co (SZSE:000963) Headlines

No Headlines